Forbes October 14, 2025
Dr. Sai Balasubramanian, M.D., J.D.

Precision health and medicine giant Verily announced today that it will be partnering with CU Anschutz and UCHealth to create an AI enabled ecosystem entailing research ready biomedical pipelines and datasets. In addition, the partnership is aiming to build curated AI models across a variety of specific therapeutic and drug areas, such as oncology, musculoskeletal and transplant medicine, to name a few. All of this work will be done using CU Anschutz’s vast research datasets via Verily Workbench, one of the company’s flagship products.

Workbench is a secure research environment which enables deep analytics for multimodal biomedical data. Importantly, the platform enables researchers to dial into varying degrees of computational analytics, bring structure to multimodal datasets that are otherwise not...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: AI (Artificial Intelligence), Partnerships, Pharma / Biotech, Precision Medicine, Technology, Trends
JPM 2026: Genoa Ventures’ Jenny Rooke on Next-Gen Clinical Assessment Tools
From Early Detection to Targeted Therapy: How AI is Reframing Precision Medicine
How Precision Medicine and AI are Evolving: An MD Anderson Perspective
Bringing Precision Medicine Into the Home
Inside the Virtual Cell: New Depths for Precision Medicine

Share Article